市場調査レポート

商品コード

1766582

血液製剤市場：製品カテゴリー別、用途別、技術別、患者属性別、エンドユーザー別、地域別

Blood Products Market, By Product Category, By Application, By Technology, By Patient Demographics, By End User, By Geography

出版日: 2025年06月09日
発行: Coherent Market Insights
ページ情報: 英文 140 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 668,115円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,039,290円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,484,700円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.47円

全表示
概要
目次

概要

サンプル依頼リストに入れる

血液製剤市場は、2025年には382億米ドルと推定され、2032年には526億9,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は4.7%で成長する見込みです。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	382億米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年CAGR：	4.70%	2032年の価値予測	526億9,000万米ドル

世界の血液製剤市場は、慢性疾患の蔓延、輸血需要の増加、血液処理・保存技術の進歩などを背景に、近年著しい成長を遂げています。全血、赤血球、血小板、血漿、その他の誘導体を含む血液製剤は、様々な医療処置や治療において重要な役割を果たしています。この市場には、アルブミン、免疫グロブリン、凝固因子、その他の血漿由来製品など、幅広い製品が含まれています。世界のヘルスケア産業が進化を続け、救命用血液製剤の需要が高まるにつれて、血液製剤市場は今後数年間で大きく成長する見込みです。

市場力学：

世界の血液製剤市場は、その成長を促進し、拡大を抑制し、利害関係者に機会を提供するいくつかの重要な要因の影響を受けています。市場促進要因のひとつは、がん、心血管障害、血液疾患などの慢性疾患の有病率の増加であり、これらの疾患は輸血やその他の血液関連治療を必要とすることが多いです。さらに、世界の老人人口の増加と外科手術の増加も、血液製剤の需要増に寄与しています。しかし、市場には、採血、処理、保存に関連する高コストや輸血感染リスクなどの抑制要因もあります。さらに、規制要件が厳しく、血液製剤の保存期間が限られていることも、市場成長の課題となっています。このような市場抑制要因にもかかわらず、血液製剤市場には、高度な血液処理技術の開発、血液バンクにおける自動化導入の増加、血漿由来療法の拡大など、大きな成長機会が存在します。さらに、ヘルスケアインフラの改善と医療費の増加に牽引された新興国における血液製剤需要の高まりは、市場企業に大きな成長見通しをもたらしています。

本調査の主な特徴

本レポートは、世界の血液製剤市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模（10億米ドル）および複合年間成長率（CAGR）を提供しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の血液製剤市場の主要企業をプロファイルしています。
このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
世界の血液製剤市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の血液製剤市場を分析する際に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 38.20 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.70%	2032 Value Projection:	USD 52.69 Bn

The global blood products market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases, the rising demand for blood transfusions, and advancements in blood processing and storage technologies. Blood products, including whole blood, red blood cells, platelets, plasma, and other derivatives, play a crucial role in various medical procedures and treatments. The market encompasses a wide range of products such as albumin, immunoglobulins, coagulation factors, and other plasma-derived products. As the global healthcare industry continues to evolve and the demand for life-saving blood products rises, the blood products market is poised for substantial growth in the coming years.

Market Dynamics:

The global blood products market is influenced by several key factors that drive its growth, restrain its expansion, and present opportunities for stakeholders. One of the primary drivers of the market is the increasing prevalence of chronic diseases, such as cancer, cardiovascular disorders, and hematological conditions, which often require blood transfusions and other blood-related treatments. Additionally, the growing geriatric population worldwide, coupled with the rising incidence of surgical procedures, contributes to the heightened demand for blood products. However, the market also faces certain restraints, including the high costs associated with blood collection, processing, and storage, as well as the risk of transfusion-transmitted infections. Moreover, stringent regulatory requirements and the limited shelf life of blood products pose challenges to market growth. Despite these restraints, the blood products market presents significant opportunities for growth, such as the development of advanced blood processing technologies, the increasing adoption of automation in blood banks, and the expansion of plasma-derived therapies. Furthermore, the rising demand for blood products in emerging economies, driven by improving healthcare infrastructure and increasing healthcare expenditure, offers substantial growth prospects for market players.

Key Features of the Study:

This report provides in-depth analysis of the global blood products market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Grifols, CSL Behring, Fresenius Kabi, Octapharma, Takeda Pharmaceutical Company, Sanofi, Kedrion Biopharma, Biotest AG, Mitsubishi Tanabe Pharma Corporation, HemaCare, BloodCenter of Wisconsin, Terumo BCT, Prothera Biosciences, American Red Cross, and Vitalant
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood products market

Market Segmentation

Product Category Insights (Revenue, USD Bn, 2020 - 2032)
- Whole Blood
- Blood Components
- Red Blood Cells (RBCs)
- Platelets
- Plasma
- White Blood Cells (WBCs)
- Cryoprecipitate
- Plasma-derived Products
- Immunoglobulins
- Albumin
- Coagulation Factors
- Hyperimmune Globulins
- Others
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Hematology
- Immunology
- Neurology
- Oncology
- Hematology
- Others
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Manual Blood Collection and Processing
- Automated Blood Collection Systems
- Blood Fractionation and Plasma Separation
- Pathogen Reduction Technologies
- Precision Blood Typing and Grouping Systems
- Others
Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric Patients
- Adult Patients
- Geriatric Patients
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Blood Banks
- Ambulatory Surgical Centers
- Transfusion Centers
- Diagnostic Laboratories
- Research Institutions
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Grifols
- CSL Behring
- Fresenius Kabi
- Octapharma
- Takeda Pharmaceutical Company
- Sanofi
- Kedrion Biopharma
- Biotest AG
- Mitsubishi Tanabe Pharma Corporation
- HemaCare
- BloodCenter of Wisconsin
- Terumo BCT
- Prothera Biosciences
- American Red Cross
- Vitalant

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Blood Products Market, By Product Category
- Global Blood Products Market, By Application
- Global Blood Products Market, By Technology
- Global Blood Products Market, By Patient Demographics
- Global Blood Products Market, By End User
- Global Blood Products Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Blood Products Market, By Product Category, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Whole Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Components
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Red Blood Cells (RBCs)
  - Platelets
  - Plasma
  - White Blood Cells (WBCs)
  - Cryoprecipitate
Plasma-derived Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Immunoglobulins
  - Albumin
  - Coagulation Factors
  - Hyperimmune Globulins
  - Others

5. Global Blood Products Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Blood Products Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Manual Blood Collection and Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Automated Blood Collection Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Fractionation and Plasma Separation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pathogen Reduction Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Precision Blood Typing and Grouping Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Blood Products Market, By Patient Demographics, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Blood Products Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Banks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transfusion Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Blood Products Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Grifols
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CSL Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius Kabi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Octapharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kedrion Biopharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biotest AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mitsubishi Tanabe Pharma Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HemaCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BloodCenter of Wisconsin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo BCT
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Prothera Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
American Red Cross
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vitalant
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

血液製剤市場：製品カテゴリー別、用途別、技術別、患者属性別、エンドユーザー別、地域別

Blood Products Market, By Product Category, By Application, By Technology, By Patient Demographics, By End User, By Geography

市場力学：

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の血液製剤市場、製品カテゴリー別、2020年～2032年

第5章世界の血液製剤市場、用途別、2020年～2032年

第6章世界の血液製剤市場、技術別、2020年～2032年

第7章世界の血液製剤市場、患者属性別、2020年～2032年

第8章世界の血液製剤市場、エンドユーザー別、2020年～2032年

第9章世界の血液製剤市場、地域別、2020年-2032年

第10章競合情勢

第11章アナリストの推奨事項

第12章参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Blood Products Market, By Product Category, 2020-2032, (USD Bn)

5. Global Blood Products Market, By Application, 2020-2032, (USD Bn)

6. Global Blood Products Market, By Technology, 2020-2032, (USD Bn)

7. Global Blood Products Market, By Patient Demographics, 2020-2032, (USD Bn)

8. Global Blood Products Market, By End User, 2020-2032, (USD Bn)

9. Global Blood Products Market, By Region, 2020 - 2032, Value (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

血液製剤市場：製品カテゴリー別、用途別、技術別、患者属性別、エンドユーザー別、地域別

Blood Products Market, By Product Category, By Application, By Technology, By Patient Demographics, By End User, By Geography

市場力学：

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の血液製剤市場、製品カテゴリー別、2020年～2032年

第5章 世界の血液製剤市場、用途別、2020年～2032年

第6章 世界の血液製剤市場、技術別、2020年～2032年

第7章 世界の血液製剤市場、患者属性別、2020年～2032年

第8章 世界の血液製剤市場、エンドユーザー別、2020年～2032年

第9章 世界の血液製剤市場、地域別、2020年-2032年

第10章 競合情勢

第11章 アナリストの推奨事項

第12章 参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Blood Products Market, By Product Category, 2020-2032, (USD Bn)

5. Global Blood Products Market, By Application, 2020-2032, (USD Bn)

6. Global Blood Products Market, By Technology, 2020-2032, (USD Bn)

7. Global Blood Products Market, By Patient Demographics, 2020-2032, (USD Bn)

8. Global Blood Products Market, By End User, 2020-2032, (USD Bn)

9. Global Blood Products Market, By Region, 2020 - 2032, Value (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の血液製剤市場、製品カテゴリー別、2020年～2032年

第5章世界の血液製剤市場、用途別、2020年～2032年

第6章世界の血液製剤市場、技術別、2020年～2032年

第7章世界の血液製剤市場、患者属性別、2020年～2032年

第8章世界の血液製剤市場、エンドユーザー別、2020年～2032年

第9章世界の血液製剤市場、地域別、2020年-2032年

第10章競合情勢

第11章アナリストの推奨事項

第12章参考文献と調査手法